新加坡ASLAN Pharma 
ASLAN总部位于新加坡，是面向全球市场研发新型药物的医药公司。ASLAN从全球医药公司引进临床前和临床分子，专注于肿瘤、呼吸道和炎症性疾病。ASLAN充分利用中国、韩国、澳大利亚及新加坡等国的资源，高效地将候选药物投入临床研究，并计划与医药公司合作，共同完成晚期全球研发和市场化。

ASLAN is an Asia enabled pharmaceutical company that develops novel medicines for global markets.

ASLAN inlicenses preclinical drugs that are up to 6-12 months from the clinic
ASLAN uses its own financial resources and high quality CRO facilities to perform preclinical, Phase 1 and 2 studies on the partnered compounds
ASLAN gets Proof of Concept (PoC) for the partnered compounds in Asia
ASLAN outlicenses PoC compounds back to partner for global development and launch